source
- Alphabet reshuffles AI leadership as DeepMind CEO steps down to become chief scientistAlphabet announced a reorganization of its artificial intelligence leadership. Demis Hassabis will leave his role as chief executive of Google DeepMind and take on the position of chief scientist f…
- Pathos AI acquires bispecific ADC from Alphamab and secures AstraZeneca partnershipPathos AI announced it will pay $125 million upfront for the rights to JSKN016, a bispecific TROP2/HER3 antibody‑drug conjugate from China’s Alphamab Oncology. The agreement also includes up to $2.…